Gilman,. 1984). There is recent evidence, however, that the binding of LH or. hCG ...... (George et a!., 1986) have no effects on the ligand- binding characteristics.
BIOLOGY
OF
REPRODUCTION
40,
1-12
Molecular
J.
HANNU
(1989)
Structure
of the
RAJANIEMI,
ULLA
KARl
Luteinizing
P. KEINANEN,
E. PETAJA-REPO, Biocenter
Hormone
and
Receptor’
SAKARI
M. KALERVO
KELLOKUMPU, METSIKKO
and Department of Anatomy University of Oulu SF-90220
Oulu
Finland INTRODUCTION
terization
A great deal has been learned years about the mechanisms hormone (hCG) target
(LH) exert cells.
binding
to
surface of Markkanen Rajaniemi, mediated
human
chorionic
their endocrine control The action of LH and a common the
1981). activation
evidence,
the past ten luteinizing
the
receptor
however,
that
on
the
1980; Abramowitz 1984). There
the
binding
hCG also activates other plasma membrane enzymes such as polyphosphoinositide-specific pholipase C. This suggests that second
of
recent possible
methodological to purify the
is
the
or
Attempts linking results,
is a single
90 kDa
special
concept
that
glycopolypeptide.
necessary. LH receptor task, however.
high
LH the
to identify techniques however. Ji
have
proved to be and structural
receptors 1984). The stable under
(Pilch and cross-linked denaturing
of their molecular sulfate-polyacrylamide and autoradiography.
the LH receptor have produced and his coworkers
molecular
weight
using crosscontradictory were among
radiolabeled
porcine granulosa cells, suggesting ture for the receptor (Ji and Ji, 1981,
The has Only it
amounts to enable The purpose of progress in the charac-
‘This work was supported by grants from the Academy Cultural Foundation of Finland, and the Emil Aaltonen requests: Hannu Rajaniemi, M.D., Biocenter ment of Anatomy, University of Oulu, Kajaanintie 52 Oulu, Finland.
techniques identification
of membrane Ruoho et al., complexes are
1985;
Nishimura
et
complexes
al.,
composed 28 kDa,
of four subunits 24 kDa, and
of molecular 18 kDa, the
containing subunits
one disulf
each to
copy of ide-linked
that
1986;
They
al., 1986a,b). et a!. have
proposed
The cross-linking suggested that the
techIn a several in
a multimeric 1980, 1981;Ji
1986a,b).
contains four subunits kDa, 58 kDa, and the
with the
the first to use different affinity cross-linking niques to characterize LH receptor structure. long series of investigations, they identified
into the action,
advances have rendered receptor in an active, hormone-
binding form and in sufficient reliable structural characterization. this article is to discuss recent
structure
substantiating
conditions, enabling estimation size by sodium dodecyl gel electrophoresis (SDS-PAGE)
is
LH
characterization of the components involved in
signal transduction pathways molecular characterization of turned out to be a very difficult
receptor
characterization Czech, 1984; radiolabeled
effector phosmessengers
1987; Allen et al., 1988). To gain an insight molecular mechanisms of LH (and hCG) and structural and the other
receptor
Affinity cross-linking highly useful for the
other than cyclic adenosine 3’, 5’-monophosphate may also play a significant role in the action of LH and hCG (Davis et al., 1986a,b, 1987; Dimino et a!.,
purification receptor
LH
LH evidence
IDENTIFICATION OF THE LH RECEPTOR BY AFFINITY CROSS-LINKING AND LIGAND BLOTTING TECHNIQUES
1) (Catt et al., 1976; 1980; Metsikk#{246} and
et al., Gilman,
on
gonadotropin
This results in guanine nucleotideof the adenylate cyclase in the (Dufau 1982;
of
emphasis
upon the gonadal hCG is initiated by
high-affinity
target cell (Fig. and Rajaniemi,
plasma membrane and Birnbaumer, recent
and
during whereby
the
with each
strucet al.,
Shin LH
et
al.,
receptor
is
sizes 34 kDa, holoreceptor
the three largest other (Shin et
experiments rat ovarian
of Menon LH receptor
of molecular sizes 89 46 kDa (Hwang and
kDa, 80 Menon,
1984a,b), while the testicular receptor consists of three subunits of molecular sizes 121 kDa, 83 kDa, and 52 kDa (Zhang and Menon, 1988). The size of
of Finland, Foundation. and DepartA, SF-90220
the 1
holoreceptor
in both
tissues
can
be calculated
to
2 be
RAJANIEMI
approximately
250-280
the subunits were found hormone binding (Hwang
kDa. to and
Interestingly,
participate Menon,
in 1984b;
all specific Zhang
one
other research findings that hormone-binding
90-100 Rajaniemi,
kDa
unit
(Rebois 1982,
groups, support
1984;
et
including ours, have the existence of only of
al.,
a molecular 1981;
Rebois,
size
of
Metsikk#{246} and 1982;
Ascoli
and
Segaloff, 1986; Petaja et al., 1987). This concept is also supported by a recent study in which a monoclonal antibody that inhibited hCG binding to the membrane receptor recognized only a 90 kDa polypeptide in a detergent extract membranes (Podesta et al., 1986). The reasons for the contradictory by affinity cross-linking techniques
of
rat
Leydig
cell
results obtained with regard to the
FIG 1. Electron microscopic autoradiograph demonstrating luteal cells. The autoradiograph is prepared from pseudopregnant The figure shows a capillary in the center and four luteal cells
AL.
molecular
size
receptor linking
and Menon, 1988). Rapoport et al. (1984) showed, however, that of the multiple labeled species in the rat ovary, only one, a 86 kDa component, exhibits the saturable hormone binding expected of the LH receptor. Using affinity cross-linking techniques, several reported
ET
to identify certain
and
subunit
are unknown methods, which receptors intrinsic
composition
at present. have been for
small
difficulties
of
ligands,
when
the
LH
Affinity crossused successfully are
used
with
subject
to
glycopro-
tein hormones. The large size of the ligand may cause cross-linking of the receptor-bound hormone to any nearby nonreceptor protein. In addition, the dimeric nature of the hormone makes it difficult to resolve whether the labeled complexes contain both subunits or only putative the
the a- or receptor.
cells
(Ascoli
and
(Kellokumpu and rise to multiple cross-linking
j3-subunit Proteolysis Segaloff,
the localization rat ovarian tissue around it (X 12,000).
1984;
or
to the of
the
tissue
may also components
give in
experiments.
characterization (Fernandez-Pol, al.,
linked preparation
1986)
Rajaniemi, 1985a,b) hormone-binding
The ligand-blotting contributed to successful
et
covalently during
technique identification
of numerous 1982; Gershoni Eidne
of the luteinizing 2 h after the iv.
et
hormone injection
a!.,
1985;
has
substantially and structural
membrane et al., Mitani
receptor in the plasma of ‘25l-human chorionic
receptors 1983; Kroon and
Dufau,
membrane gonadotropin.
of
1986),
and
has
identification
been
of
(1987a,b)
the
in our
the spontaneous electroblotted SDS-PAGE.
STRUCTURE
OF
employed
for
successfully
LH
receptor
laboratory.
by
The
Kein#{224}nen et a!.
method
is based
renaturation of receptor onto a nitrocellulose Alternatively,
some
may retain their hormone in the presence of SDS,
receptor
binding although
A single 90 kDa hCG-binding strated with this technique Leydig tumor cells (MLTC-1),
on
molecules sheet after molecules
conformation this seems
specificity
polypeptide was demonin the rat ovary, mouse and human and bovine
characteristic
of the
(Fig. 3). On the basis of these posed that the 90 kDa polypeptide receptor or its hormone-binding this
90
kDa
and no
human major
binding
species
and bovine structural
corpora differences
LH receptor
rat
ovary,
3
receptors
in
hardly
different
unexpected
possibility
in
that obtained
or
could
explain
PURIFICATION
of the
LH
form
is a prerequisite
tion.
Although
some
et can
a!.,
1981; et
be
al.,
Wimalasena 1983),
solubilized
interorgan the
for
most
and
of
mamthe
(testis
vs.
contradictory techniques.
in a biologically
its ultimate have receptor Dufau,
experiments
quantitatively
is
role
LH RECEPTOR
receptor
LH
This
control of also excludes
investigators
of water-soluble
central
cross-linking
OF THE
active existence
of the
the hormonal This result
by different
Solubilization
species.
light
interspecies
differences
results
mammalian in the
the LH receptor malian reproduction.
sena
results, we have prorepresents the LH unit. The presence of
in the
RECEPTOR
ovary)
even unlikely.
corpora lutea (Fig. 2) (Kein#{228}nen et a!., 1987a,b; Kein#{228}nen and Rajaniemi, 1988). The binding of hCG to this polypeptide exhibited the saturability and hormone
LH/hCG
only
purificareported
species
the (Khan
1982;
Wimala-
indicate
that
it
in detergents.
MLTC-1,
lutea suggest also exist between
that LH
12345 kDa
1234.5678 kDa 116205-
94--
116-
66-
‘-i1#{149} 66-
45-. 45-
FIG.
2.
Identification
of
the
luteinizing
hormone
receptors
from
four mammalian species. Triton X-100 extract of pseudopregnant rat ovarian membranes (Lanes 1 and 2), and N-acetylglucosamine eluate of wheat germ agglutinin affinity chromatography of solubilized mouse Leydig tumor cells (Lanes 3 and 4) or solubilized bovine luteal membranes (Lanes 5 and 6) and Triton X-100 extract of human luteal membranes (Lanes 7 and 8) were subjected to SDS-PAGE under nonreducing conditions and electroblotted onto a nitrocellulose sheet. The nitrocellulose strips were incubated with ‘‘I-human chorionic gonadotropin (hCG) in the absence (Lanes 1, 3, 5, and 7) or presence of an excess of unlabeled hCG (Lanes 2, 4, 6. and 8).
FIG. 3. Saturability and hormone specificity of the ‘“I-human chorionic gonadotropin (hCG) binding to protein blots from pseudopregnant rat ovary. Solubilized membrane proteins were separated by SDS-PAGE under nonreducing conditions and electroblotted onto a nitrocellulose sheet. The nitrocellulose strips were incubated with ‘251-hCG in the absence (Lane 1) or presence of unlabeled hCG (101W ml) (Lane 2), human luteinizing hormone (10 lU/mi) (Lane 3), rat follicle-stimulating hormone (2 sg/ml) (Lane 4) or rat prolactin (2 p5/ ml) (Lane 5).
RAJANIEMI
4 Thus, the membrane Singer
LH receptor protein in
and
can the
Nicholson
solubilized X-100 and
be regarded operational
(1972).
the rat testicular demonstrated that
Dufau
properties analyses suggested
asymmetric molecule mass of 190-200 kDa
with (Dufau
Rebois
1973;
Catt
ity b)
et a!., et al.,
Its
in
a
et
raphy
a!.
(1973)
lability
(Dufau
and obstacle
and
et al.,
and
in
sufficient amounts for detailed structural and functional analyses. An important methodological advance in the solubilization of gonadotropin receptors was the finding by Dias et al. (1981) that glycerol
recently,
but
the
garding reports
its size generally
results
have
ability on thus making
whether the polypeptide SDS gels represented real nating proteins. In one
1. Purification The solubilized
of rat receptor
was
luteinizing purified by
re-
activity
factors binding
contributing activity were
cal 90
purified to assess
Preparation
Homogenate Membranes Triton X.100 extract 1st affinity eluate 2nd affinity eluate
the
aAs
determined
bAs
measured
soluble CND,
758 338 226
1000 917 1098 456 137
0.109 0.018 by by
fractions. not determined.
the the
saturation method
analysis of Lowry
of “5l-hCG et al. (1951)
analyses
(n
on
=
1987a).
The
major
the retention of hormonepresence of 20% glycerol
revealed
in
inclusion of the ethylenedi-
that
contained
Data are from hCG-Affi-Gei
to receptor
which
only
is over
calculated capable of the compared
ovarian second
the
purified
a single
class
70%
of
the
of
specific with
purification by KeinInen
binding hormone
±
theoreti-
to be 11000 pmol/mg of binding one molecule
homogenate, affinity step
a representative 10 as described
for
activity binding
a of
was to
and the receptor yield averaged 15%. When the
from 100 ovaries et al. (1987a).
(7.23
g of
bindin? activity
4150 7580
homogenate
4),
Enrichment 6000-fold
1.32 2.71 4.86
binding
to the
preparation
the total after the
Specific (pmol/mg)
in the
have improved the of the LH receptor to retention of its hormone-
(EDTA), and phenylmethylsul(PMSF) in all solutions in the purificaTable 1 summarizes the results of a purification from 100 ovaries. Equilib-
maximum, kDa receptor
hCG. over
‘251-hCG Activity (pmol)
a preliminary
we
(Kein#{228}nen et al.,
binding
protein
hormone (LH) receptor. affinity chromatography
proteinb (mg)
only
laboratory reported from rat ovaries using and elution of the
high-affinity binding sites for hCG, with a Kd of 5.1 2.6 X i0#{176} M (n = 3). The specific binding capacity of the purified receptor was 7920 ± 432 pmol/mg
bands seen in the stained receptor units or contamiearly paper, Dufau et al.
ovarian
binding
receptor
the
gave
of the LH chromatog-
receptor at low pH (Metsikk#{246} and Rajaniemi, Metsikk#{246}, 1984). The purified receptor prepacontained only one major 90 kDa glycopolybut its hormone-binding activity was substan-
rium
The earlier of any specific
the part of it difficult
but
purification affinity
Later, our of the LH receptor chromatography
aminetetraacetate fonyl fluoride tion procedure. representative
of the appeared
conflicting
and subunit composition. lacked firm evidence
hormone-binding polypeptides,
TABLE tissue).
been
hCG-Affi-Gel
using
the solubilized preparations and the proteinase inhibitors N-ethylmaleimide,
effectively stabilizes the solubilized calf testicular follicule-stimulating hormone (FSH) receptor. Later, Ascoli (1983) showed a similar stabilizing effect of glycerol on the LH receptor as solubilized from cultured mouse Leydig tumor cells. Numerous reports describing purification LH receptor from various sources have
15,000-fold testes
rat
tially reduced. Recently, procedure to allow purification near homogeneity with full
susceptibil-
form
on
bound 1982; ration peptide
Rajaniemi, 1985a, to its successful
hormone-binding
described from
characterization. purification hCG affinity
in this solubilized of the detergentthat it is a highly
1983)
(Kellokumpu a major
(1975) receptor
an apparent molecular et al., 1973;Metsikk#{246},
1976;Ascoli,
to proteolysis have formed
purification
1987).
AL.
as an integral definition of
LH receptor in Triton it retained its character-
istic hormone binding form. Hydrodynamic solubilized LH receptor
1984;
ET
Affin ity (KD) M (X 10-10)
Yield
NDC ND 3.1 ND
100 91.7 109.8 45.6
4.0
Purification factor
%
1 2.05 3.68 3143 5742
13.7
preparations. and
membranes
and
by
the
method
of Schaffner
and
Weissman
(1973)
in
OF LH/hCG
STRUCTURE
purified SDS-PAGE
receptor under
preparation was either nonreducing
conditions, only one appeared, demonstrating receptor and that it linked subunits (Fig.
subjected to or reducing
major 90 kDa polypeptide the high purity of the does not contain covalently 4). The 90 kDa polypeptide
RECEPTOR
The
slight
difference
size of 90 to different lous
5 between
kDa obtained electrophoretic
(1987)
et
al.,
have
properties 1980).
Interestingly,
recently
reported
showed specific hormone binding in ligand blotting (Fig. 5) and formed a 130 kDa complex with radio-
identical to those obtained basis of affinity purification
labeled
the rat testicular polypeptide.
LH
The papers cited male LH receptors
above infer are composed
purified receptor. does since
hormone,
indicating
90 kDa Moreover,
conclusively
polypeptide it is conceivable
not contain no other
that
represents that the
any nonhormone-binding polypeptides were
the
the LH receptor
subunits, copurified in
stoichiometric amounts relative to the 90 kDa species. These results agree well with recent reports by Wimalasena et al. (1985) and Kusada and Dufau (1986, 1988) that purified porcine and rat luteal LH receptors have the form of single polypeptides with molecular masses of 68 kDa and 73 kDa, respectively.
kDa
glycopolypeptide.
LH-receptor Dattatreyamurty
al.
1
molecular
may be assigned and/or anomaof
glycoproteins Minegishi
results
et
at.
essentially
by use, concluding on the and ligand blotting that receptor
is
a single
that of
Totally
structure et
the
different
have (1983)
90
kDa
both female and a single 68-90 views
on
also been reported. purified the bovine
luteal LH receptor using conventional protein cal separation methods and found the preparations to consist of a highly aggregated
12345 kDa
and
in our study conditions
electrophoretic
(Leach
these
chemipurified protein
234
kDa ‘
205-
116-
11694-
.,
66-’.
11 45-
FIG.
4. SDS-PAGE
66-
-.
45-,
of
the
purified
rat
ovarian
luteinizing
hormone
(LH) receptor preparations. Reduced samples from various stages of purification were subjected to SDS-PAGE on 7.5% acrylamide separating gel and 5% stacking gel, and the gels were stained with silver. Lane 1, Triton X-100 extract; Lane 2, purified LH receptor after first human chorionic gonadotropin (hCG)-Affi-Gel 10 chromatography; Lane 3, purified LH receptor after second hCG-Affi-Gel 10 chromatography; Lane 4, control purification in which the LH receptors were attached to the affinity column in the presence of an excess of soluble hCG; Lane 5, mass standards.
5. Demonstration of the hormone-binding activity of the puriovarian luteimzing hormone receptor by ligand blotting. Triton x-ioo extract (Lane 1) and three purified receptor preparations (Lanes 2, 3, and 4) after the second human chorionic gonadotropin (hCG)-AffiGel 10 chromatography were subjected to SDS-PAGE under nonreducing conditions and electroblorted onto nitroceliulose. The nitrocellulose strips were incubated with ‘251-hCG. fied
FIG. rat
6 that
RAJANIEMI
produced
a 280
denaturation. dissociated
Upon first to
kDa
species
in SDS-PAGE
reduction, a 120-140
the kDa
confined molecular
only mass
to the 120 forms (Saxena
sizes binding
receptor,
consisting
light
38
Bruch
kDa
et
receptor obtained
al.
of
chains (1986)
from a 268
dissociated
four
may
be
interchange, and 80 kDa polypeptide
that
a more however, an
which in
and
to
lead
structure.
The
by most recent been assigned
erroneous bands
molecular
caused
size
the same molecular by
disulfide
in primary purification al., 1982), research subunits
produced
in the
receptor receptor
stained
our
type
experiment
of glycosidic
purified
(Kein#{228}nen,
iodinated
glycopeptidase between the
rat
F(PNGase proximal
linkage
ovarian
1988),
(N-linked
LH
in glycoproteins (Tarentino in a decrease in the molecular from 90 kDa to about 62
whereas
neuraminidase
shift from contrast, minidase, (0-linked) the size receptor receptor
90 kDa treatment
of
treatment
treatment
of
receptors
F), which cleaves N-acetyl-glucosamine
paragine resulted receptor
caused
with the bond and as-
et
al., size
kDa only
1985), of the (Fig. 6), a slight
to about 79 kDa (Fig. with endo-a-N-acetylgalactosa-
7).
In
which cleaves the serine-threonine-linked oligosaccharide side chains, did not affect of the intact or neuraminidase-treated iodo(Fig. 7). These results suggest that the LH contains mainly N-linked oligosaccharide
bone Kusuda
of which the size
the receptor is and Dufau (1988)
carry terminal sialic acid of the polypeptide backapproximately have reported
62 kDa. somewhat
group to be are
SDS
careful controls or direct demonstrations hormone-binding ability of these polypeptides. thus possible that some of the proposed polypeptides may also represent nonspecific
In
cultures of one but a
at of
receptor
preparations subunits
the
side chains, some residues, and that
1985a,b) may components of
and
or 0-linked), have not been elucidated until very recently (Kusada and Dufau, 1988; Kein#{228}nen, 1988).
a single Biosyn-
results preparation
interpretations
purified to LH
LH
ovaries, and upon reduction
receptor is in fact and Bahl, 1987).
and Rajaniemi, hormone-binding
two
bonds.
recent report, that the high
subsequent experiment by the same allowed three additional receptor identified. The reasons for these contradictory present unknown. Proteolysis during (Kellokumpu to multiple
and of the
the
thetic labeling of the LH receptor of rat Leydig cells resulted in the 79 kDa polypeptide (Aubry et
the tissue give rise
kDa
disulfide rat
artifact
the (Sojar
suggested bovine LH
purification
subunits In
85 by
pseudopregnant kDa protein,
to
species
heavy
stabilized reported
range 46-79 kD. laboratory suggests, mass
two
of 85 was
kDa dimer and higher et a!., 1986). Based on
these results, Dattatreyamurty et al. (1983) an immunoglobulin-like structure for the
AL.
receptor,
upon
280 kDa species species and then
to two dissimilar subunits with molecular kDa and 38 kDa. Specific hormone
ET
1
2
3
4
kDa 205-
gels
have without of
the It is receptor contam-
inants. GLYCOSYLATION
The evident bound lectin
OF THE
LH RECEPTOR
45-
glycoprotein nature of the LH receptor is from numerous reports. The receptor is to and specifically eluted from wheat germ and
concanavalin
A (MetsikkO
and
Rajaniemi,
1982; Kusuda and Dufau, 1986; Keinanen et al., 1987a), and may be chemically labeled using carbohydrate-specific labeling techniques (Metsikk#{246}, 1984). The contribution of oligosaccharide side chains to the size and hormone-binding properties of the LH
FIG. 6. Effect of glucopeptidase (PNGase) F on the electrophoretic mobility of the ‘251-Iabeled rat ovarian luteinizing hormone receptor. lodoreceptor was incubated at 30#{176}C either alone (Lane 1) for 4 h or with PNGase F (4 U/mi) for 1 (Lane 2), 2 (Lane 3), or 4 h (Lane 4). The products were precipitated by 10% trichioroacetic acid and subjected to SDS-PAGE and autoradiography.
STRUCTURE
similar
results,
showing
N-linked oligosaccharide tion of the purified
that
enzymatic
OF
removal
of
side chains caused a reducreceptor from 80 kDa to 54
LH
LH/hCG
RECEPTOR
yet
been
7 obtained
deglycosylated a hormonal
to
the
receptor
question
is still
of
capable
whether
the
of transmitting
signal.
kDa. The seem
glycan to be
binding. PNGase 62
moiety necessary
the for
We have found F-treated rat ovarian
kDa
binding
polypeptide
complete agreement the iodoreceptor rium-binding tions
of
in
with (Fig.
analysis the
the receptor compared also agree receptors,
amount
does not hormone
(Kein#{228}nen, membranes in
ligand
1988) that produce a blotting,
in
the results obtained with 8). In addition, an equilib-
showed or
LH receptor high-affinity
no
significant
hormone-binding
alteraaffinity
TRANSMEMBRANE
To
gain
membrane
an
insight
signaling
upon its membrane recently, only a few membrane
of
1985a,b).
in the PNGase F-treated membranes as with untreated membranes. These results with those obtained with i3-adrenergic showing that enzymatic deglycosylation
approach bearing
by
OF THE
receptor To [125
extensive Rajaniemi, portion of out-oriented
into
the
the
LH
mechanism receptor,
of
of
any
(Kellokumpu
address
this
question,
trans-
information
topography is needed. reports existed concerning
topography
activating
(Cervantes-Olivier et at., 1985; Stiles, 1985) or inhibition of receptor glycosylation with tunicamycin (George et a!., 1986) have no effects on the ligandbinding characteristics of the receptor. No answer has
TOPOGRAPHY
LH RECEPTOR
adenylate and we
Until the cyclase-
Rajaniemi, adopted
an
in which rat I] -hCG-labeled
ovarian receptors
membrane vesicles were subjected to
chymotrypsin 1986). This
treatment removes
(Keinanen and the extracellular
the occupied vesicles but
receptor only the
in the right-sidecytoplasmic exten-
123 1
2
3
4
kDa
kDa
205116-
1166645.-.
45-
FIG. 7. Effect of neuraminidase and endo-o-N-acetyigalactosaminidase on the electrophoretic mobility of the ‘251-labeled rat ovarian iuteinizing hormone receptor. lodoreceptor was incubated for 3 h at 30#{176}Calone (Lane 1), with neuraminidase (50 mU/mI) (Lane 2), with neuraminidase (50 mU/mi) plus endo-a-N-acetylgalactosaminidase (25 U/mI) (Lane 3) or with endo--N-acetylgalactosaminidase (25 U/mI) (Lane 4). The reaction products were analysed by SDS-PAGE and autoradiography after precipitation by 10% trichloroacetic acid.
FIG. 8. Detection of the rat ovarian luteinizing hormone (LH) receptor by ligand blotting after glycopeptidase (PNGase) F treatment of the membranes. Membranes were incubated in the presence or absence of PNGase F (10 U/mI) for 2 h at 30#{176}C.After solubilizauon, the digesteed receptor was subjected to SDS-PAGE under nonreducing conditions and electroblotted onto nitrocellulose. The niuocelluose strips were incubated with ‘251-human chorionic gonadotropin. Lanes I and 3, untreated control membranes; Lane 2, PNGase F-treated membranes.
RAJANIEMI
8
ET
Sian ifl the inside-out-oriented vesicles, the truncated receptor being retained in the membranes. Extensive chymotrypsin treatment released 70-75% of the radioactivity initially bound to the ovarian membrane
ment.
vesicles in a 1-h-incubation. the water-soluble radioactivity three complexes with molecular
the of
kDa,
and
tory
have
61 kDa.
Previous
demonstrated
SDS-PAGE analysis released pointed masses of 96 kDa,
experiments that
endogenous
and trypsin treatment of ovarian in the release of similar complexes, kDa
and
74 kDa
and 38 kDa (Kellokumpu suggest molecule oriented
complexes
and
can
be
released
1
by
proteolysis results the 96
to the
64 kDa
linked 1985a,b).
part of 90 kDa)
labora-
membranes and that
correspond
receptor fragments and Rajaniemi,
that a substantial (64 kDa out of
in our
of to 74
to intact hCG These results the LH receptor is extracellularly
proteolytic
AL.
Further
increase membrane
the
chymotrypsin
release vesicles,
hormone-occupied
treatment
of radioactivity indicating that
from the 25-30%
receptors
protected
are
enzyme and probably exposed toward the inside-out vesicles. When the
chymotrypsin-resistant
radioactivity
and subjected to SDS-PAGE, observed (Fig. 9), whereas produced
a
130
kDa
for
the
laboratory et al.,
finding
was
a 110 kDa untreated
complex,
other findings in our Rajaniemi, 1982; Peta:ja explanation
did
cited
in
ovarian of the from
the interior solubilized cross-linked complex was membranes
agreement
(Metsikko 1987). The here
not
is that
with and salient while
most of the LH receptors reside in the right-side-out vesicles, some 25-30% are situated in the inside-out vesicles and that the decrease in size of the hormone-
treat-
1234
2
kDa
kDa 205-
116-’ 94-
94-:.,
66-
00
45-
FIG. 9. Detection of the cross-linked membrane-retained proteolytic products of ‘251-human chorionic gonadotropin (hCG)-receptor complex by SDS-PAGE and autoradiography. Rat ovarian membrane vesicles, labeled with 125l-hCG in vivo, were subjected to chymotrypsin (1 mg/mI) treatment for 60 mm at 37#{176}C.The membrane-retained proteolytic products of the ‘“l-hCG-receptor complex were solubilized and subjected to SDS-PAGE after cross-linking with glutaraldehyde. Lanes I, membrane-bound hormone receptor complex from control incubation (enzyme omitted); Lane 2, membrane-retained proteolytic products of hormone receptor complex produced by chymotrypsin.
FIG. 10. Detection of the membrane-retained proteolytic products of the free luteinizing hormone (LH) receptor by ligand blotting. Rat ovarian membrane vesicles bearing free LH receptor sites were subjected to an identical incubation as in Figure 9. The chymotrypsin-treated membranes were solubilized, subjected to SDS-PAGE under nonreducing conditions, and electrobiotted onto nitrocellulose. The nitroceilulose strips were incubated with ‘“I-human chorionic gonadotropin (hCG) in the absence (Lanes I, 2) or presence (Lanes 3. 4) of an excess of unlabeled hCG. Lanes I and 3, intact receptor; Lanes 2 and 4, chymotrypsin-treated receptor.
STRUCTURE
receptor
complex
by
about
20
kDa
is due
OF
to proteo-
lytic cleavage of the cytoplasmic domain of the receptor in these inside-out vesicles. This concept was supported by the finding that enrichment of the inside-out doubled
vesicles by the fraction
chymotrypsin
digestion.
ovarian membrane with chymotrypsin retained
that
bearing analysis
cated in 70 kDa
the inside-out-oriented binding polypeptide,
receptor
took
similar
the
conditions
with results suggests that
form (Fig.
molecule complex.
to
al., hCG
ligand
free
a 90 This
kDa
lo-
produced a the intact species
is in good
affinity change
and Taken
blotting
receptors
vesicles whereas
of 10).
obtained by the molecular
the receptor moiety of the
the
under
agreement
cross-linking and in fact occurs in
not in together,
the hormone these results
support the transmembrane nature of the LH receptor. Moreover, if the receptor traverses the lipid bilayer only once, then the 20 kDa domain released by chymotrypsin digestion will be entirely exposed intracellularly, so that it must thus represent the cytoplasmic
domain
of the
INTERACTION
LH receptor.
OF hCG SUBUNITS
WITH
THE
LH RECEPTOR
questions are through
1987)
antibodies
recognize
whereas generally suggests tact
ties, but
whereas can be
intact dimeric receptor-binding
gonadotropins and biological
the separate reassociated with
biological activity Parson, 1981). On demonstrated that
subunits are full recovery
(Catt et al., the other hand, the dissociated
1976; recent subunits
have
with
intrinsic activity, although very limited, as shown by the ability of the purified a-subunits of LH and hCG (Moudgal and Li, 1982) and synthetic peptides corresponding a-subunit (Charlesworth
to internal (Keutmann et al.,
et 1987)
amino
acid
sequences
(Keutmann
al., 1987) and a-subunit of hCG to compete with
et al.,
1987).
the
a-subunit
of
complex,
the
receptor
and
thus
beyond
the
reach.
subunit (Petaja
([‘251]-hCG) or et al., 1987).
receptor receptor PAGE
complex (130 complex (105 and autoradiography,
in its a-subunit Only the intact
of
we hCG, its a-
([3H1-hCG) hormone-
kDa) and the a-subunit kDa) were found in SDSthe latter being particu-
larly distinct after reduction. This suggests that the LH receptor binds one hormone molecule and that the major interaction of hCG with the receptor occurs through its a-subunit (Fig. 11) (Petaj#{228}et al., 1987). Essentially by Kusuda and
identical results Dufau (1986).
contact receptor
between the demonstrated
plexing common
as it is well known to all the glycoprotein
have been reported The apparent close
a-subunit of hCG and in these is somewhat that the hormones
the
a-subunit and that
LH peris it
123456
kDa
kDa
-205 130105
116
-94
-
-66
(M ()
-
-
h CO h O
-
______
-45
()-hCO
in the
the intact hormone for receptor binding. In addition, the synthetic a-subunit peptides are reported to have weak steroidogenic activity, although at micromolar concentrations
against
hormone-receptor
the specific antibodies. To address this question, have carried out affinity cross-linking tests with which carries the radioactive label either in
the activi-
and has some
activation of hCG interacts
the antibodies against the a-subunit do not recognize the receptor-bound hCG. This that the a-subunit is in more intimate con-
inactive of their
Pierce research have
directed the
Gonadotropins, including hCG, are composed of two dissimilar subunits, of which the a-subunit is responsible for species specificity and the a-subunit for hormone specificity. According to numerous reports, only characteristic
regarding the which subunit
with its gonadal receptor and what is the valency of the receptor. A number of polyclonal (Milius et al., 1983) and monoclonal (Moyle et al., 1982; Bidart et
of
by
of
Interesting receptor
treatment
free receptor sites of the membrane-
components
proteolysis
the
9
RECEPTOR
chromatography resistant
Identical
vesicles and
receptor
showed
lectin-affinity of radioactivity
LH/hCG
FIG. 11. Interaction of the human chorionic gonadotropin (hCG) subunits with rat ovarian luteinizing hormone (LH) receptor. Membranes were incubated with ‘I-hCG (a-subunit-labeled) (Lanes 1-3) or ‘HhCG (-subunit-iabeled) (Lanes 4-6) in the absence (Lanes 1, 2, 4, 5) or presence (Lanes 3, 6) of an excess of unlabeled hCG and solubiized in 1% Triton X-100. Samples were subjected to SDS-PAGE both under nonreducing (Lanes 1, 3, 4, 6) and reducing (Lanes 3, 5) conditions after cross-linking with glutaraldehyde. In the 7.5% separating gel, the a- and a-subunits of hCG migrated at the dye front.
10
RAJANIEMI
is the
a-subunit
specificity.
that
To
should
be
this
remembered
hypothesized of all other two tor,
is responsible
explain
for
apparent that
the
Milius
et
al.
it (1983)
(and analogously takes place
steps. First, the a-subunit recognizes the forming an initial transient complex.
through
a structural
is formed
transformation,
between
the
a stable
a-subunit
and
in
the
DOMAIN
receptor.
1987).
model
binding
evidence show that
membranes with
two-step
changes
is also
offered by hCG binding from
90 kO
supported
Katikineni to rat
a “loose”
EXT RACELLUL AR
complex
at least in the hormone as evidenced by changes epitopes (Moyle et at.,
This
N-Linked Oligosaccharide Side Chains
recepThen,
Structural changes take place upon binding to the receptor, in the availability of antigenic by kinetic (1980) to
AL.
hormone
discrepancy,
that the binding of hCG glycoprotein hormones)
ET
et al. testicular
to a “tight”
form TRANSMEMBRANE
PLASMA
time.
DOMAiN CONCLUSIONS
Advances
in
conformation
of
AND
FUTURE
stabilizing the
PROSPECTS
the
receptor
INTRACELLULAR
hormone-binding
by
means
of
glycerol
and in identification of the receptor have rendered it possible to purify
by ligand blotting LH receptors in an
active,
and
hormone-binding
form
amounts to enable reliable structural and production of antibodies. The
in
sufficient
characterization available results
from our laboratory are summarized in Figure 12, which proposes a schematic structure for the LH receptor. The receptor consists of a single 90 kDa transmembrane glycopolypeptide with a 64 kDa extracellular hormone-binding domain and a 20 kDa cytoplasmic domain. It contains several N-linked oligosaccharide side chains that do not participate in high-affinity hormone binding, and its polypeptide backbone has a molecular mass of 62 kDa. The receptor interaction its
binds one of hCG
a-subunit.
molecule with the
Structural
of hCG, receptor conservation
receptor in different mammalian by ligand-blotting data on the human. As regards the proposed of
the
receptor,
absence of amino that the receptor brane
more
The LH hypothetical tions. determine plasma
than receptor and
it is worth
cannot
model involves
of
the
LH
species is suggested rat, mouse, cow, and membrane insertion
emphasizing
acid sequence polypeptide once
and the major occurs through
data, the may span
that
in the
possibility the mem-
DOMAiN
FIG. 12. Proposed izing hormone receptor. illustrates the 62 kDa
structure and membrane insertion of the luteinThe curved line spanning the plasma membrane polypeptide backbone of the receptor.
Kusuda and Dufau (1988) imply that the LH receptor tends to dimerize in purified form, and the same authors suggest that its functional form may in fact be a homodimer of the 90 kDa species. This result needs to be confirmed by other techniques, however, e.g., The question should of the tute ous
by a target-size of putative
be resolved, purified 90
LH-responsive system. Future
elucidating
gram
amounts
to look
the
into
be excluded. proposed here many unresolved
adenylate work the
1985). units
the capacity to reconsti-
cyclase in a heterologshould also be aimed
molecular
receptor Finally,
of pure
further
(Venter, receptor
e.g., by measuring kDa receptor species
in detail
the coupling of effector enzymes.
analysis additional
events
with plasma the availability
receptor
now
its molecular
makes
involved
at in
membrane of microit possible
biology.
ACKNOWLEDGMENTS
is highly ques-
Investigations are particularly needed to the functional form of the receptor in the membrane. The results published recently by
The Eero
Oja,
skillful and
technical Sirkka
Martti
assistance
of
is gratefully
Sirpa
JmsI,
Paula
Soininen,
acknowledged.
REFERENCES Abramowitz gonadotropin
J,
Birnbaumer interaction
L, 1982. with rabbit
Temporal lutes]
characterisiecs receptors and
of activa-
STRUCTURE
OF
don of adenylyl cyclase: comparison to the mode of action of catecholamine receptors. Endocrinology 111:970-76 Allen RB, Su HC, Snitzer J, Dimino J, 1988. Rapid decreases in phosphatidylinositol in isolated lutes] plasma membranes after stimulation by luteinizing hormone. Biol Reprod 38:79-83 Ascoli M, 1983. An improved method for the solubilization of stable gonadotropin receptors. Endocrinology 113:2129-34 Ascoli M, Segaloff DL, 1986. Effects of collagenase on the structure of the lutropin/choriogonadotropin receptor. J Biol Chem 261: 3807-15 Aubry M, Collu R, Ducharme JR, Crine P, 1982. Biosynthesis of a putative gonadotropin receptor component by rat Leydig cells: isolation of a radiolabeled acidic protein of 79,000 molecular weight by affinity chromatography. Endocrinology 11:2129-3 1 Bidart J-M, Troalen F, Salesse R, Bousfield GR, Bohuon CJ, Bellet DH, 1987. Topographic antigenic determinants recognized by monocloncal antibodies on human choriogonadotropin (3-subunit. J Biol Chem 262:8551-56 Bruch RC, Thotakura NR, Bahl OP, 1986. The rat ovarian lutropin receptor. Purification, hormone binding properties, and subunit composition. j Biol Chem 261:9450-60 Catt KJ, Ketelslegers JM, Dufau ML, 1976. Receptors for gonadotropic hormones. In: Blecher M (ed.), Methods in Receptor Research, Part I. New York: Marcel Dekker, pp. 175-250 Cervantes-Olivier P, Durieu-Trautmann 0, Delavier-Klutchko C, Strosberg AD, 1985. The oligosaccharide moeity of the jl,-adrenergic receptor from turkey erythrocytes has a biantennary, N-acetyllactomsamine-containing structure. Biochemistry 24: 3 765-70 Charlesworth MC, McCormick DJ, Madden B, Ryan Ri, 1987. Inhibition of human choriogonadotropin binding to receptor by human choriogonadotropin a peptides. J Biol Chem 262: 13409-16 Dattatreyamurty B, Rathnam P, Saxena BB, 1983. Isolation of the luteinizing hormone-chorionic gonadotropin receptor in high yield from bovine corpora lutea. Molecular assembly and oligomeric structure. J Biol Chem 258:3140-58 Davis JS, Weakiand LL, Farese RV, West LA, 1987. Luteinizing hormone increases inositol trisphosphate and cytosolic free Ca2 in isolated bovine lutes] cells. J Biol Chem 262 :8515-21 Davis JS, Weakland LL, West LA, Farese RV, 1986a. Luteinizing hormone stimulates the formation of inositol trisphosphate and cyclic AMP in rat granulosa cells Biochem J 238:597-604 Davis
JS, West LA, Weakland LL, Farese RV, 1986b. Human chorionic gonadotropin activates the inositol 1, 4, 5-trisphosphate-Ca’#{176} intracellular signalling system in bovine lutes] cells. FEBS Lett 208: 287-91 Dias JA, Huston JS, Reichert LE Jr, 1981. Effect of the structure-stabilizing agent glycerol on detergent-solubilized follicle-stimulating hormone receptors from calf testis. Endocrinology 109:736-41 Dimino MJ, Snitzer J, Brown KM, 1987. Inositol phosphate accumulation in ovarian granulosa cells after stimulation by luteinizing hormone. Biol Reprod 37:1129-34 Dufau ML, Baukal AJ, Catt KJ, 1980. Hormone-induced guanyl nucleotide binding and activation of adenylate cyciase in the Leydig cell. Proc NatI Acad Sci USA 77:5837-41 Dufau ML, Ryan DW, Baukal AJ, Catt KJ, 1975. Gonadotropin receptors. Solubilization and purification by affinity chromatography. I Biol Chem 250:4822-24 Eidne KA, Hendricks DT, Millar RP, 1985. Demonstration of a 60 K molecular weight luteinizing hormone-releasing hormone receptor in solubilized adrenal membranes by a Iigand-immunoblotting technique. Endocrinology 116:1792-95 Fernandez-Pol IA, 1982. lmmunoautoradiographic detection of epidermal growth factor receptors after electrophoretic transfer from gels to diazo-paper. FEBS Lett 143:86-92 George ST, Ruoho AE, Malbon CC, 1986. N-giycosylation in expression and function of (3-adrenergic receptors. J Biol Chem 261: 165 59-64 Gershoni JM, Hawrot E, Lentz TL, 1983. Binding of a-bungarotoxin to isolated a subunit of the acetylcholine receptor of Torpedo californica: quantitative analysis with protein blots. Proc Nati Acad Sd USA 80:4973-77 Gilman AG, 1984. G proteins and dual control of adenylate cyclase. Cell 36:577-79
LH/hCG
RECEPTOR
J,
Hwang ture
Chem Hwang
J,
11
Menon KIM, of gonadotropin 259:1978-85 Menon KMJ,
1984a.
Characterization receptor in luteinizied
1984b.
Spatial
of
the rat
relationships
subunit ovary. of
the
J
strucBiol
human
chorionic gonadotropin (hCG) subunits in the assembly of the hCG-receptor complex in the luteinized rat ovary. Proc NatI Acad Sci USA 81:4667-71 Ji I, Bock JH, Ji TH, 1985. Composition and peptide maps of crosslinked human choriogonadotropin-receptor complexes on porcine granulosa cells. J Biol Chem 260:12815-21 Jil, Ji TFl, 1980. Macromolecular photoaffinity labeling of the lutropin receptor on granulosa cells. Proc NatI Acad Sci USA 77:7167-70 Ji I, Ji TH, 1981. Both a and (3 subunits of human choriogonadotropin photoaffinity label the hormone receptor. Proc NatI Acad Sci USA 78:5465-69 Ji I, Yoo BY, Kaltenbach C, Ji TH, 1981. Structure of the lutropin receptor on granulosa cells. Photoaffinity labeling with the a subunit in human choriogonadotropin. J Biol Chem 256: 10853-58 Katikineni M, Davies TF, Huhteniemi IT, Catt KJ, 1980. Luteinizing hormone-receptor interaction in the testis: progressive decrease in reversibility of the hormone-receptor complex. Endocrinology 107:1980-88 Kein#{228}nen KP, 1988. Effect of deglycosylation on the structure and hormone binding activity of lutropin receptor. Biochem J (in press) Keinanen KP, Kellokumpu S, Metsikko MK, Rajaniemi JH, 1987a. Purification and partial characterization of rat ovarian lutropin receptor. J Biol Chem 262:7920-26 Keinanen KP, Kellokumpu S, Rajaniemi H, 1987b. Visualization of the rat ovarian lutropin receptor by ligand blotting. Mol Cell Endocr 49:33-38 Kein#{225}nen KP Rajaniemi HJ, 1986. Rat ovarian lutropin receptor is a transmembrane protein. Evidence for an Mr2OOOO cytoplasmic domain. Biochem J 239:83-87 Kein#{228}nen KP, Rajaniemi HJ, 1988. Solubilization of luteinizing hormone receptor from human corpora lutea in a stable form and identification of the hormone binding unit by ligand blotting. J Clin Endocr Metab 67:228-3 3 Kellokumpu S, Rajaniemi H, 1985a. Involvement of plasma membrane enzymes in the proteolytic cleavage of luteinizing hormone receptor. Endocrinology 116:707-14 Kellokumpu S, Rajaniemi H, 1985b. Hormone binding modified endogenous proteolysis of LH/hCG receptors in rat ovarian plasma membranes. Mol Cell Endocr 42:157-62 Keutmann HT, Charlesworth MC, Mason KA, Ostrea T, Johnson L, Ryan RJ, 1987. A receptor-binding region in human choriogonadotropin/lutropin (3 subunit. Proc NazI Acad Sci USA 84: 2038 -42 Khan
FS, Rathnam P, Saxena BB, 1981. Purification and properties of human chorionic gonadotropin/lutropin receptor from plasma membrane and soluble fractions of bovine corpora lutea. BiochemJ 197:7-22 Kroon PA, Thompson GM, Chao Y-S, 1984. A comparison of the low-density-lipoprotein receptor from bovine adrenal cortex, rabbit and rat liver and adrenal glands by lipoprotein blotting. BiochemJ 223:329-35 S, Sufau ML, 1986. Purification and characterization of the rat ovarian receptor for luteinizing hormone. Structural studies of subunit interaction. I Biol Chem 261:16161-68 Kusda S, Dufau ML, 1988. Characterization of ovarian gonadotropin receptor. Monomer and associated form of the receptor. J Biol Chem 263:3046-49 Leach BS, Collawn JF Jr, Fish WW, 1980. Behavior of glycopolypeptides with empirical molecular weight estimation methods. 1. In sodium dodecyl sulfate. Biochemistry 19:5734-41 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265 -75 Kusda
Markkanen SO, Rajaniemi H, 1980. Role of internalization and degradation in the removal of receptor-bound human chorionic gonadotropin in rat lutes] cells in vivo. Endocrinology 109:1399-1403 Metsikk#{246} MK,
1984.
Covalent
labelling
of
the
lutropin
binding
site.
12
RAJANIEMI Evidence 2 19:583-91
for
a single
Mr
90,000
sialoglycopolypeptide.
Biochem
ET
J
Metsikk#{246} MK, Rajaniemi H, 1981. Antibodies to purified luteinizing hormone receptor localize the receptor at the lutes] cell surface. Endocrinology 109:1399-1403 Metsikko MK, Rajaniemi HJ, 1982. The hormone-binding unit of luteinizing hormone receptor. Biochem J 208:309-16 Metsikk#{246} MK, Rajaniemi Hi, 1984. lmmunoprecipitation of the lutropin receptor. Loss of receptor molecules during down-regulation. Biochem J 224:467-71 RP, Midgley AR Jr, Birken S, 1983. Preferential masking by the receptor of immunoreactive sites on the a-subunit of human chorionic gonadotropin. Proc Nat] Acad Sci USA 80:7375-79 Minegishi T, Kusuda S, Dufau ML, 1987. Purification and characterization of Leydig cell luteinizing hormone receptor. J Biol Chem 262: 17138-43 Mitani M, Dufau ML, 1986. Purification and characterization of prolacdii receptors from rat ovary. J Biol Chem 261:1309-15 Moudgal NR, Ki CH, 1982. (3 subunits of human choriogonadotropin and ovine lutropin are biologically active. Proc Nat] Acad Sci USA 79:2500-03 Moyle WR, Ehrlich PH, Canfield RE, 1982. Use of monoclonal antibodies to subunits of human chorionic gonadotropin to examine the orientation of the hormone in its complex with receptor. Proc Nat] Acad Sci USA 79:2245 -49 Moyle WR, Pressey A, Dean-Emig D, Anderson DM, Demeter M, 1987. Detection of conformations] changes in human chorionic gonadotropin upon binding to rat gonads] receptors. J Biol Chem 262: 16920-27 Nishimura R, Raymond MJ, Ji I, Rebois RV, ii TH, 1986. PhotoMilius
Petaj
affinity labeling and deglycosylated 83 :63 27-3 1 U, Kellokumpu
of
the gonadotropin choriogonadotropin.
5, Keinanen
K,
receptor Proc Metsikko
with Nat]
native, asialo, Acad Sci USA
K, Rajaniemi
H, 1987.
Covalent cross-linking of radiolabeled human chorionic gonadotropin to rat ovarian luteinizing hormone receptor with glutaraldehyde. J Rec Research 7:809-27 Pierce JG, Parsons TF, 1981. Glycoprotein hormones: structure and function. Ann Rev Biochem 50:465-95 Pilch PF, Czech MP, 1984. Affinity cross-linking of peptide hormones and their receptors. In Venter JC, Harrison LC (eds.), Receptor Biochemistry and Methodology. New York: Alan R Liss, pp. 161-75 Podesta EJ, Solano AR, Sanchez ML, 1986. Luteinizing hormone triggers two opposite regulatory pathways through an initial common event, receptor aggregation. Endocrinology 119: 989-97 Rapoport B, Hazum E, Zor U, 1984. Photoaffinity labeling of human chorionic gonadotropin-binding sites in rat ovarian plasma mem-
AL. branes.
J
Biol Chem
259:4267-71
Rebois Ky, 1982. Establishment of gonadotropin-responsive murine Leydig tumor cell line. J Cell Biol 94:70-76 Rebois RV, Bradley RM, Titlow CC, 1987. Hydrodynamic properties of the gonadotropin receptor from a murine Leydig tumor cell line are altered by desensitization. Biochemistry. 26:6422-28 Rebois Ky, Omedeo-Sale F, Brady RO, Fishman PF, 1981. Covalent crosslinking of human chorionic gonadotropin to its receptor in rat testes. Proc Nat] Acad Sci USA 78:2086-89 Ruoho AE, Rashidbaigi A, Roeder PE, 1984. Approaches to the identification of receptors utilizing photoaffinity labeling. In: Venter JC, Harrison LC (eds.), Receptor Biochemistry and Methodology. New York: Alan R Liss, pp. 109-18 Saxena BB, Dattatreyaznurry B, Ota H, Milkov V, Kathnasn P. 1986. Subunits of luteinizing hormone-human chorionic gonadotropin receptor from bovine corpora lutea. Biochemistry 25:7943-50 Schaffner W, Weissman C, 1973. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem 56: 502-14 Shin J Jil, Ji TH, 1986a. Disulfides of the lutropin receptor. J Biol Chem 261:7501 -06 Shin J, Ji I, Ji TH, 1986b. Structural homologies in the lutropin/human choriogonadotropin receptor and the follitropin receptor on porcine granulosa cells. Biochemistry 25:3410-15 Singer SJ, Nicholson GL, 1972. The fluid mosaic model of the structure of cell membranes. Science 175:720-31 Sojar HT, Bahi OP, 1987. Role of sulhydryl groups in rat ovarian lutropin receptor aggregation. I Cell Biol 105:314a Stiles GL, 1985. Deglycosylated mammalian fi2-adrenergic receptors: effect on radioligand binding and peptide mapping. Arch Biochem Biophys 237:65-71 Tarentino AL, Gomez CM, Plummer TH Jr. 1985. Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F. Biochemistry 24:4665-71 Venter JC, 1985. Size of neurotransmitter receptors as determined by radiation inactivation/target size analysis. In: Conn PM (ed), The Receptors, Vol. 2. New York: Academic Press, pp. 245-80 Wimalasena J, Dufau ML, 1982. Water-soluble gonadotropin receptors of the rat ovary. Endocrinology 110:1004-12 Wimalasena J, Moore P, Wiebe JP, Abel J Jr, Chen TT, 1985. The porcine LI-I/hCG receptor. Characterization and purification. J Biol Chem 260:10689-97 Wimalasena J, Schwab 5, Dufau ML, 1983. Soluble luteinizing hormone! human chorionic gonadotropin receptors of the rat ovary: comparative studies of waterand detergent-soluble receptors. Endocrinology 113:618-24 zhang Q-Y, Menon KMJ, 1988. Characterization of rat Leydig cell gonadotropin receptor structure by affinity cross-linking. J Biol Chem 263:1002-07